Raloxifene |
Raloxifene Products |
| Consider Raloxifene a Safe Alternative to HRT.(hormone replacement therapy ): An article from: Family Practice News Kate Johnson International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Raloxifene linked to reduced risk of stroke, TIA. (In High-Risk, Postmenopausal Women).(transient ischemic attack): An article from: Internal Medicine News Mitchel L. Zoler International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Raloxifene being tested for premenopausal chemoprevention. (Well Tolerated So Far in Open-Label Trial).: An article from: Internal Medicine News International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Head-to-head comparison of osteoporosis drugs: alendronate vs. raloxifene.(Women's Health): An article from: Family Practice News Kate Johnson International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Raloxifene, PTH are good osteoporosis combo: together, the two drugs could potentially maximize the formation and minimize the resorption of bone.(Musculoskeletal ... An article from: Family Practice News Timothy F. Kirn International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Breast ca prevention could be next for raloxifene. (Phase II Data).(breast cancer): An article from: Family Practice News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Lipid profiles of nonwhite women benefit from raloxifene: posthoc analysis.(Women's Health): An article from: Family Practice News Michele G. Sullivan International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Raloxifene and PTH may have synergistic effect on BMD.(Rheumatology)(bone mineral density): An article from: Internal Medicine News Timothy F. Kirn Thomson Gale Thomson Gale |
Sale Price: $5.95
|
| Coronary events fall 40% with Raloxifene therapy: results 'as good as in the statin trials'. (Secondary Analysis of Osteoporosis Trial).(Brief Article): An article from: Family Practice News Bruce Jancin International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Raloxifene appears cardioprotective in high-risk women: the data come from a secondary analysis of a 4-year osteoporosis study. (Preliminary Data).: An article from: Internal Medicine News Bruce Jancin International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Raloxifene surprises with cardioprotective benefits. (Analysis of Osteoporosis Trial Data).: An article from: Family Practice News Mitchel L. Zoler International Medical News Group The Gale Group International Medical News Group |
Sale Price: $5.95
|
| Drug update: prevention of osteoporosis in postmenopausal women.(bisphosphonates, raloxifene, estrogen replacement, and teriparatide): An article from: Family Practice News Mitchel L. Zoler, Doug Brunk International Medical News Group International Medical News Group |
Sale Price: $5.95
|
| Extended raloxifene continues to protect some.: An article from: Internal Medicine News Bruce Jancin International Medical News Group International Medical News Group |
Sale Price: $5.95
|

Not Signed In - 


